Home > Healthcare > Medical Services > Inpatient and Outpatient Services > Extractable and Leachable Testing Services Market

Extractable and Leachable Testing Services Market Size

Report ID: GMI8466
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Extractable and Leachable Testing Services Market Size

Extractable And Leachable Testing Services Market size was valued at around USD 866.2 million in 2023 and is anticipated to register a CAGR of over 13.6% between 2024 and 2032. Extractable and leachable testing services are vital analytical procedures across industries such as pharmaceuticals, food packaging, cosmetics, and medical devices, ensuring the safety and compliance of products.

To get key market trends

Download Free Sample

With increased recognition and investment, these services have seen advancements in methodologies, equipment, and expertise, benefiting pharmaceuticals, vaccines, and medical device testing services sectors. This progress has enabled accelerated research and development efforts, fostered the delivery of innovative drugs, vaccines, and medical devices while upheld rigorous safety and compliance standards. For instance, according to the World Health Organization (WHO) in 2021 reported a significant surge in vaccine distribution, with approximately 16 billion doses supplied globally, valued at USD 141 billion.

Extractable and Leachable Testing Services Market Report Attributes
Report Attribute	Details
Base Year:	2023
Extractable and Leachable Testing Services Market Size in 2023:	USD 866.2 Million
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	13.6%
2032 Value Projection:	USD 2.7 Billion
Historical Data for:	2018 - 2023
No. of Pages:	120
Tables, Charts & Figures:	154
Segments covered:	Product Type, Application, and Region
Growth Drivers:	Supportive regulatory framework and rising emphasis on patient safety Growing pharmaceutical and biotechnology industry Widespread adoption of single-use technology
Pitfalls & Challenges:	High cost of testing Complexity associated with extractable and leachable testing

Learn more about the key segments shaping this market

Download Free Sample

This marks a substantial increase compared to the market volume in 2019, which stood at USD 5.8 billion doses. Therefore, there is a rising need for innovative approaches and advancements in extractable and leachable testing services to ensure the safety, quality, and regulatory compliance of the increasing volume of vaccines being produced and distributed worldwide.Furthermore, growing pharmaceutical and biotechnology industry, which estimated to reach 952 billion by 2027, widespread adoption of single-use technology, among other contributing factors propelling the growth of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global extractable and leachable testing services industry was valued at around USD 866.2 million in 2023 and is estimated to reach over USD 2.7 billion by 2032, owing to growing pharmaceutical and biotechnology companies and widespread adoption of single-use technology.

Container closure systems segment of extractable and leachable testing services industry is estimated to account for USD 868.5 million by 2032, as they ensure product integrity during storage and transport, minimizing the likelihood of extractables and leachable contaminating the product, thereby preserving its quality.

North America extractable and leachable testing services market accounted for USD 351 million in 2023 and is predicted to witness substantial growth through 2032, driven by advanced technological infrastructure, including state-of-the-art laboratories in the region.

BA Sciences, Eurofins Scientific, Intertek Group plc, Limerston Capital LLP, Merck & Co., Inc., Pacific Biolabs, Inc, SGS Societe Generale de Surveillance SA, Sotera Health Co, West Pharmaceutical Services, Inc, Wickham Micro Limited, WuXi AppTec Co., Ltd. are some of the major industry contenders.